SCORE Project at Meharry Medical College-Supplement I

点击翻译按钮获取中文摘要

DESCRIPTION (provided by applicant): The long-range goal of the SCORE Program at Meharry Medical College is to assist in improving the competitive status of the school's research enterprise relative to other health science centers in the United States. The program seeks to create a research environment wherein faculty will improve their research skills and capabilities to efficiently conduct high quality research, to disseminate their research through peer-reviewed publications and presentations at national meetings, and to compete with greater success for independent extramural research funds. Finally, research projects ongoing and proposed in this SCORE supplemental application will assist the institution in its mission to conduct basic, clinical and applied research with special emphasis on diseases and conditions that disproportionately affect ethnic minority populations. The specific aims of the program are: 1) to increase the scientific productivity in terms of peer reviewed publications by MBRS investigators from approximately four papers per three years (grant years 28-30) to an average of six papers per three years (grant years 32-34), and 2) to increase the acquisition of investigator initiated grants from 10% to 20% of the investigators associated with the SCORE program by year-34. Eight regular subprojects and two pilot projects were funded in 2003 (year-32) as a result of the competing continuation application. One of the regular projects was funded as a R01 in 2004 and has been withdrawn. This supplemental application requests support for eleven regular research projects and two pilot projects. Projects are submitted from the School of Medicine departments of Biochemistry, Family and Preventive Medicine, Microbiology, Pharmacology, Physiology and Surgery. Thus the program is projected to focus on a broad spectrum of health related issues including cancer, sickle cell disease, signaling and transduction mechanisms, oral health, infectious diseases including HIV/AIDS and neuroscience.